Papiliotrema laurentii fungemia in a premature, very low-birth-weight neonate in Kuwait successfully treated with liposomal amphotericin B

2021 ◽  
Vol 31 (2) ◽  
pp. 101123
Author(s):  
Hissa Al-Otaibi ◽  
Mohammad Asadzadeh ◽  
Suhail Ahmad ◽  
Noura Al-Sweih ◽  
Leena Joseph
Infection ◽  
2000 ◽  
Vol 28 (4) ◽  
pp. 223-226 ◽  
Author(s):  
A. Juster-Reicher ◽  
E. Leibovitz ◽  
N. Linder ◽  
M. Amitay ◽  
O. Flidel-Rimon ◽  
...  

PEDIATRICS ◽  
1993 ◽  
Vol 91 (6) ◽  
pp. 1217-1218
Author(s):  
L. PEREIRA DA SILVA ◽  
J. M. VIDEIRA AMARAL ◽  
N. CORDEIRO FERREIRA

To the Editor.— Lackner et al1 report on the excellent efficacy and lack of toxicity of 1 to 5 mg/kg per day of liposomal Amphotericin-B (AmBisome) administered to two infants of very low birth weight with disseminated fungal infection. We agree with the authors when they say that success in the treatment of two cases does not allow extrapolation of the same therapeutic schedule to an infants with identical multisystemic immaturity. We would like to report two cases from our own clinical experience with distinct characteristics.


PEDIATRICS ◽  
1993 ◽  
Vol 91 (6) ◽  
pp. 1218-1218
Author(s):  
H. LACKNER ◽  
CH. URBAN

In Reply.— We read with great interest the results of Pereira da Silva and co-workers, who successfully treated two premature newborns with disseminated fungal infection using lower doses of liposomal Amphotericin-B (AmBisome) than we have reported in our paper.1 We agree with the authors that the most appropriate dosage of liposomal Amphotericin-B for the treatment of very low birth weight infants is still to be established, and that the main goal of treatment should be to use AmBisome in a dose with maximal effect but minimal toxicity.


2016 ◽  
Vol 30 (9) ◽  
pp. 1057-1059 ◽  
Author(s):  
Deepak Sharma ◽  
Ankur Patel ◽  
Priyanka Soni ◽  
Sweta Shastri ◽  
Ravinder Singh

PEDIATRICS ◽  
1988 ◽  
Vol 81 (6) ◽  
pp. 826-829
Author(s):  
Barbara Baetz-Greenwalt ◽  
B. Debaz ◽  
Mary L. Kumar

Very low birth weight infants often have multiple predisposing conditions for the development of invasive candidiasis. In patients with systemic candidiasis, the kidney is vulnerable to the formation of cortical abscesses or obstructive intrarenal masses ("fungus balls"), usually at the ureteropelvic junction. Ureteropelvic junction obstructive fungal uropathy necessitates invasive debridement to restore renal function. A very low birth weight infant, infected with Candida, was first seen with hypertension, renal insufficiency, and urine cultues positive for fungus; obstructive bladder fungus ball was diagnosed by ultrasography. Mechanical disruption with amphotericin B bladder irrigation was accomplished via ultrasographic guidance, relieving renal obstruction and insufficiency. Systemic antifungal therapy was completed with amphotericin B and flucytosine. The first reported case of bladder obstructive fungal uropathy in a neonate is added to a review of 16 cases of neonatal renal obstructive uropathy.


Sign in / Sign up

Export Citation Format

Share Document